---
$id: https://graph.org.ai/products/commodity/51112601
$type: Product
source: UNSPSC
code: "51112601"
title: "Carmustine"
class: "51112600"
classTitle: "Alkylating agent nitrosourea compounds"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Carmustine

**UNSPSC Code**: 51112601
**Class**: [Alkylating agent nitrosourea compounds](Alkylating agent nitrosourea compounds.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nitrosourea compound and dna adduct forming agent with the molecular formula C5H9Cl2N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U68WG3173Y, chemically known as 1,3-bis(beta-chloroethyl)-1-nitrosourea but more generally known as carmustine, which bears US NIH Compound Identifier 2578. European Medicines Agency schedules Carmustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06132MIG. The term CARMUSTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules carmustine in its Anatomical Therapeutic Chemical (ATC) Classification. CARMUSTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule carmustine under HS 29241900 and SITC 51471. As of Q4 2014, CARMUSTINE remains US FDA's Preferred Term for this commodity. Carmustine bears US NLM identifiers UMLS ID C0007257 and NCI Concept Code C349. SMILES: CLCCN(N=O)C(=O)NCCCL.

